Enoxaparin Sodium Injection- Anticoagulant thiab Antithrombotic CAS No.: {{{0}}.2ml:2000AxaIU(20mg), 0.4ml:4000AxaIU (40mg), 0.6ml: 6000AxaIU (60mg), 0.8ml: 8000AxaIU (80mg), 10ml: 100,000AxaIU (1g)

Lub npe tshuaj: enoxaparin sodium. Nws yog ib hom uas tsis muaj molecular hnyav heparin sodium. Nws yog sodium ntsev ntawm sulphated glucosaminoglycans, tau los ntawm alkaline degradation ntawm benzyl ester derivative ntawm heparin los ntawm porcine plab hnyuv mucosa.

Cov qauv qauv:

uas, n= 1~21; R= -H los yog -SO3Na; R1= -H lossis -SO3Na lossis COCH3;

R2=-H, R3= -CO2Na lossis R2= -CO2Na, R3=-H.

Molecular Luj: Qhov hnyav-qhov nruab nrab molecular hnyav li ntawm 3500 ~ 5500 Dalton.

[Properties]

Ntshiab, xim tsis muaj xim rau daj ntseg daj.

[Indications]

● Prophylaxis ntawm venous thromboembolic kab mob (tiv thaiv cov ntshav txhaws hauv cov hlab ntsha) tshwj xeeb yog cov uas yuav cuam tshuam nrog orthopedic lossis kev phais dav dav.

● Kev kho mob ntawm cov hlab ntsha sib sib zog nqus, nrog lossis tsis muaj pulmonary embolism (PE), tsis muaj cov tsos mob hnyav, tsis suav nrog PE yuav xav tau kev kho mob thrombolytic lossis phais.

● Kev kho mob angina tsis ruaj tsis khov thiab tsis-Q-wave myocardial infarction, muab tshuaj aspirin ib txhij.

● Kev tiv thaiv ntawm thrombus tsim nyob rau hauv cov khoom ntxiv-corporeal ncig thaum hemodialysis.

● Kev kho mob ST-segment elevation myocardial infarction, tau txais thrombolysis lossis nrog percutaneous coronary intervention (PCI).

[Lub zog]

{{0}}.4ml: 4000AxaIU; 0.6ml: 6000AxaIU

[Kev tswj hwm thiab noj tshuaj]

1 mg (0.01 ml) ntawm enoxaparin sodium sib raug kwv yees li 100 IU anti-Xa kev ua haujlwm (100 AXa IU).

Enoxaparin sodium yuav tsum tau txhaj los ntawm txoj kev sib sib zog nqus subcutaneous hauv kev tiv thaiv cov kab mob venous thromboembolic, kev kho mob ntawm cov hlab ntsha sib sib zog nqus, kev kho mob ntawm cov hlab ntsha tsis ruaj khov thiab tsis-Q-wave myocardial infarction, thiab los ntawm txoj hauv kev intravascular thaum lub sij hawm hemodialysis hauv cov hlab ntsha ntxiv; Rau kev kho mob ntawm ST-segment elevation myocardial infarction, enoxaparin sodium yog txhaj thawj zaug los ntawm txoj hlab ntshav thiab ua raws li txoj kev sib sib zog nqus subcutaneous.

Tsis txhob txhaj tshuaj ntawm txoj kev intramuscular.

Kev txhaj tshuaj subcutaneous:

Cov syringes pre-filled yog npaj txhij-rau-siv. Cov cua npuas los ntawm lub syringe yuav tsum tsis txhob raug tshem tawm ua ntej txhaj tshuaj. Kev txhaj tshuaj subcutaneous yuav tsum zoo dua yog ua nrog tus neeg mob supine. Enoxaparin sodium yog siv nyob rau hauv cov ntaub so ntswg subcutaneous ntawm lub anterolateral los yog posterolateral plab phab ntsa, alternated ntawm sab laug thiab sab xis. Tag nrho qhov ntev ntawm rab koob yuav tsum tau qhia txog perpendicularly, tsis yog tangentially, rau hauv daim tawv nqaij quav tsim ntawm tus ntiv tes xoo thiab ntiv tes. Cov tawv nqaij no yuav tsum tau tuav thoob plaws hauv kev txhaj tshuaj.

Cov txheej txheem txhaj tshuaj tsuas yog rau kev kho mob ntawm ST-segment nce myocardial infarction:

Thaum Enoxaparin sodium yog siv los ntawm cov kab mob hauv cov hlab ntsha, nws yuav tsum tsis txhob sib xyaw lossis ua ke nrog lwm cov tshuaj. Txhawm rau kom tsis txhob muaj qhov sib xyaw ua ke ntawm enoxaparin nrog rau lwm cov tshuaj, cov tshuaj nkag mus rau hauv cov hlab ntsha uas tau xaiv yuav tsum tau yaug nrog cov kua ntsev txaus lossis dextrose kua ua ntej thiab ua raws li kev tswj hwm cov tshuaj intravenously ntawm enoxaparin kom tshem tawm qhov chaw nres nkoj ntawm cov tshuaj. Enoxaparin tej zaum yuav muaj kev nyab xeeb nrog cov tshuaj ntsev ib txwm (0.9 feem pua) lossis 5 feem pua ​​dextrose hauv dej.

Initial 3000 AXa IU kev tswj hwm txoj hlab ntshav:

Tuav 3000 AXa IU (0.3 ml) ntawm enoxaparin hauv cov koob txhaj tshuaj, thiab tshem tawm cov kua dej uas tsis muaj ntxiv lawm. Txhaj 3000 AXa IU bolus ncaj qha rau hauv cov hlab ntsha.

Ntxiv intravenous bolus rau percutaneous coronary intervention (PCI):

Rau cov neeg mob uas tau tswj hwm nrog kev cuam tshuam nrog percutaneous coronary intervention (PCI), yog tias qhov kawg ntawm enoxaparin subcutaneous kev tswj hwm tau muab ntau dua 8 teev ua ntej kev nce siab hauv lub zais pa, yuav tsum tau txhaj tshuaj ntxiv rau hauv cov hlab ntshav ntawm 30 AXa IU / kg ntawm enoxaparin.

Txhawm rau kom paub tseeb qhov tseeb ntawm qhov ntim me me yuav tsum tau txhaj, nws raug nquahu kom dilute cov tshuaj mus rau 300 AXa IU / ml.

Txhawm rau kom tau txais 300 AXa IU / ml tov, siv 6000 AXa IU enoxaparin sodium pre-filled syringe, nws raug nquahu kom siv 50 ml infusion hnab (piv txwv li siv 0.9 feem pua ​​​​cov tshuaj saline ib txwm lossis 5 feem pua. dextrose hauv dej) raws li hauv qab no:

Tshem tawm 30 ml ntawm lub hnab infusion nrog ib lub syringe thiab muab pov tseg cov kua. Txhaj tag nrho cov ntsiab lus ntawm 6000 AXa IU enoxaparin sodium pre-filled syringe rau hauv 20 ml seem hauv lub hnab. Sib tov cov ntsiab lus ntawm lub hnab maj mam. Tshem tawm qhov yuav tsum tau ntim ntawm diluted tov nrog ib tug syringe rau intravenous txhaj.

Tom qab dilution tiav lawm, qhov ntim yuav tsum tau txhaj tshuaj tuaj yeem suav nrog cov qauv hauv qab no [ ntim ntawm cov tshuaj diluted (ml) {{0}} tus neeg mob qhov hnyav (kg) × 0.1], lossis siv cov lus hauv qab no. Nws raug nquahu kom npaj cov dilution tam sim ua ntej siv.

[Npe]

Lub Npe Lub Npe: Enoxaparin Sodium Txhaj Tshuaj

● Tsuas yog LWMH pom zoo los ntawm ACC, ESC thiab CSC los kho UA thiab NSTEMI.

● Tsuas yog LWMH pom zoo los kho STEMI.

● Tsuas yog enoxaparin sodium uas ua raws li EP 8.0 tus qauv, thiab muaj EU thiab Asmeskas cov txheej txheem patent hauv Suav teb.

● Ua raws li cov qauv yam ntxwv t ntawm thawj cov tshuaj Lovenox/Clexane, piv nrog rau lwm cov tshuaj generic, YINUOJIA muaj siab tshaj biologically sib npaug thiab tshwj xeeb tus nqi ntawm anti-FXa/anti-FIIa kev ua. Muaj kev pheej hmoo los ntshav thiab muaj kev nyab xeeb siab.

● Tau txais qhov kev txhawb nqa tshwj xeeb ntawm kev tsim kho tshuaj tshiab hauv lub xeev pawg sab laj, thiab cov khoom plig zoo tshaj plaws ntawm lub xeev patent rau kev tsim khoom, Class B tshuaj ntawm National Medical insurance, Cov tshuaj Basic hauv qee lub xeev thiab nroog.

Dosage Form: Txhaj

Specification: {{0}}.4ml: 4000AxaIU; 0.6ml: 6000AxaIU

[Indication]

1. Kev tiv thaiv kab mob venous thromboembolic, tshwj xeeb tshaj yog thrombosis txuam nrog orthopedic lossis kev phais dav dav.

2. Kev kho mob ntawm qhov tob venous thromboembolic nrog lossis tsis muaj pulmonary embolism.

3. Kev tiv thaiv ntawm thrombus tsim nyob rau hauv lub extra-corporal ncig thaum hemodialysis.

4. Kev kho mob angina tsis ruaj tsis khov thiab tsis-Q-wave myocardial infraction, ua ke nrog tshuaj aspirin.

Kev kho mob ntawm ST-segment nce myocardial infarction nrog thrombolytics lossis ua ke nrog percutaneous coronary intervention (PCI).

Tuam txhab Profile

Hangzhou Jiuyuan Genetic Engineering Co., Ltd. yog lub teb chaws high-tech enterprise tshwj xeeb hauv kev tshawb fawb thiab kev tsim kho, tsim khoom thiab muag cov tshuaj genetic engineering, khoom siv orthopedic thiab tshuaj tshuaj. Lub tuam txhab tau tsim nyob rau lub Kaum Ob Hlis 1993. Raws li ib tug tswv cuab ntawm Hangzhou East China Pharmaceutical Group Holding Co., Ltd., nws yog ib qho ntawm cov tuam txhab tshuaj genetic engineering thaum ntxov tsim nyob rau hauv xeev Zhejiang thiab txawm nyob rau hauv tag nrho lub teb chaws.

Jiuyuan Gene ua raws li lub tswv yim ntawm "kev siv cov noob caj noob ces raws li cov lus qhia thiab pab txhawb rau tib neeg kev noj qab haus huv", ua siab tawv tsim kho thiab nrhiav kev ua tau zoo. Thaum Lub Kaum Hli 1996, lub tuam txhab tau coj tus thawj coj los ua kom muaj kev vam meej thiab kev lag luam ntawm cov ntshav dawb-txhawb cov tshuaj tshwj xeeb-Jilifen (rhG-CSF), rhuav tshem kev lag luam kev lag luam los ntawm Asmeskas thiab Nyij Pooj cov tuam txhab thiab tau txais lub koob npe nrov ntawm "Tuam Tshoj thawj zaug txhaj tshuaj". Rau ntau tshaj li ob xyoo lawm, Jiuyuan Gene tau ua tiav pib Ji Lifen, Ji Pai Lin, Ji Jufen, Yi Zhe Jia, Ji Ou Ting thiab Pob Txha Youdao series ntawm cov khoom.

Lub tuam txhab Honour

Zhejiang xeev ib mu tau txais txiaj ntsig ua lag luam

Gene-engineering Tshiab Tshuaj R & D Technology thiab Kev Pabcuam Sub-platform

Provincial Post-doctoral Scientific Research Working Center

Cov khoom lag luam zoo heev hauv Zhejiang Xeev

Hangzhou Academician Expert Working Center

Hangzhou Sab saum toj Kaum Tshiab High-tech Enterprise

Zhejiang Green Enterprise

Manufacturing thiab Quality

Ua raws li lub tswv yim ntawm "zoo los ntawm kev tsim", cov qauv kev ua tau zoo yog siab dua li cov kev cai sab nraud.

Qhia txawv teb chaws cov cuab yeej siv siab heev rau cov txheej txheem tseem ceeb.

Cov kab ntau lawm ntawm JILIFEN formulated bulk tau dhau EU GMP ntawv pov thawj.

FAQ

Q: Koj lub sijhawm them nyiaj yog dab tsi?

A: 30 feem pua ​​​​ntawm cov nyiaj them poob haujlwm ua ntej tsim khoom thiab 70 feem pua ​​​​ntawm cov nyiaj them ua ntej xa khoom.

Q: Koj muaj daim ntawv pov thawj twg?

A: GMP, EUGMP thiab ISO14001.

Q: Koj qhov kev pabcuam shipping yog dab tsi?

A: Peb tuaj yeem muab kev pabcuam rau nkoj nkoj, kev sib sau khoom, kev tshaj tawm kev lis kev cai, kev npaj cov ntaub ntawv thauj khoom thiab xa khoom ntau ntawm qhov chaw nres nkoj shipping.

Cim npe nrov: enoxaparin sodium txhaj- anticoagulant thiab antithrombotic, cas no .: {{0}}.2ml:2000axaiu(20mg) , 0.4ml:4000axaiu(40mg), 0.6ml:6000axaiu(60mg), 0.8ml:8000axaiu(80mg), 10ml:100,000axaiu(1g), Tuam Tshoj enoxaparin sodium txhaj- anticoagulant thiab antithrombotic, cas no .: 679809-58-6 0.2ml: 2000axaiu (20mg), 0.4ml: 4000axaiu (40mg), 0.6ml: 6000axaiu (60mg), 0.8ml: 8000axaiu (800 mg), 10ml: 100,000axaiu (1g) manufacturers, lwm tus neeg, Hoobkas